Neural Implants Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Neural Implants Market Grow Between 2026 And 2030?
The neural implants market has experienced substantial expansion in recent times. This market is projected to expand from $5.91 billion in 2025 to $6.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.4%. Historically, this expansion has been driven by factors such as the rising incidence of neurological disorders, an expanding population of patients suffering from chronic pain, increased uptake of deep brain stimulation therapies, the proliferation of neurology specialty centers, and a growing body of clinical evidence supporting neuromodulation.
The neural implants market is projected to experience substantial expansion over the upcoming years. This market is set to reach $9.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Several factors contribute to this projected growth, including progress in implantable neurotechnology, an expanding elderly demographic experiencing neurological disorders, a heightened need for tailored neurology treatments, the proliferation of outpatient neurological interventions, and increased funding for neurotechnology research. Key trends anticipated during this period encompass the increasing acceptance of neurostimulation treatments for chronic ailments, the growing deployment of implantable devices to address movement disorders, the broadening clinical endorsement of brain-computer interface technologies, the extension of neuromodulation applications beyond solely managing pain, and a heightened requirement for enduring solutions in neurological disorder management.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report
Which Primary Drivers Are Impacting The Neural Implants Market Growth?
The neural implants market is expected to experience growth driven by the increasing incidence of neurological disorders. A neurological disorder is defined as any condition of the nervous system involving anatomical, biochemical, or electrical anomalies in the brain, spinal cord, or peripheral nerves. These disorders have become more common due to factors such as aging populations, genetic predispositions, and evolving diagnostic criteria. Neural implants are designed to treat and manage various neurological diseases by directly interfacing with the nervous system to restore or improve neural functions. These implants offer a personalized approach, which can enhance the effectiveness of therapy while potentially reducing adverse effects, particularly in conditions like Parkinson’s disease, epilepsy, and spinal cord injuries. For instance, in 2024, the Department of Health and Human Services, a US-based federal cabinet-level department dedicated to protecting the health and well-being of Americans, reported that over 6 million Americans were living with Alzheimer’s disease in 2023. Forecasts project that this number will significantly increase each year as the population ages, reaching 13 million by 2060. Thus, the escalating prevalence of neurological disorders is a significant factor propelling the expansion of the neural implants market.
What Are The Different Segment Types In The Neural Implants Market Segment Breakdown?
The neural implants market covered in this report is segmented –
1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)
2) By Application: Chronic Pain, Parkinson’s Disease (PD), Epilepsy, Other Applications
3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers
Subsegments:
1) By F And B Spinal Cord Stimulation (SCS): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation
2) By Deep Brain Stimulation (DBS): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs
3) By Vagus Nerve Stimulation (VNS): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators
Which Trends Are Shaping Growth In The Neural Implants Market?
Major companies in the neural implant market are focused on developing innovative products, such as deep brain stimulation (DBS) devices, to treat movement disorders like Parkinson’s disease and essential tremors, thereby gaining a competitive edge. Deep Brain Stimulation (DBS) devices are medical implants that treat neurological disorders by delivering electrical impulses to specific brain areas. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, launched Liberta RC, which is the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, designed for individuals with movement disorders. It requires the fewest recharges of any FDA-approved DBS system, needing only 10 recharge sessions per year for most users. This product integrates with Abbott’s proprietary NeuroSphere virtual clinic, allowing customers to contact clinicians, confirm proper settings and functionality, and receive updated treatment settings remotely. The system incorporates a wireless charger that can be placed over the product, enabling users to remain active while wearing it. The device also provides customers with useful notifications and customized settings to ensure a personalized charging experience.
Who Are The Well-Known Companies In The Neural Implants Market?
Major companies operating in the neural implants market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp., NeuroPace Inc., Axonics Modulation Technologies Inc., Saluda Medical, Nuvectra Corporation, Cerbomed GmbH, Inspire Medical Systems Inc., Synchron Inc., Blackrock Neurotech, Neuralink, BrainGate, Bioinduction Ltd, SetPoint Medical, CereGate, Gyrus ACMI, Aleva Neurotherapeutics
Get The Full Neural Implants Market Report:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report
Which Region Has The Greatest Market Share In The Neural Implants Market?
North America was the largest region in the neural implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neural Implants Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report
Browse Through More Reports Similar to the Global Neural Implants Market 2026, By The Business Research Company
Implantable Neurostimulation Devices Market Report 2026
Smart Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report
Microelectronic Medical Implants Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
